Ignite Creation Date:
2024-10-26 @ 3:35 PM
Last Modification Date:
2024-10-26 @ 3:35 PM
Study NCT ID:
NCT06511401
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-07-05
Brief Title:
Informing Pain Treatment Using Pharmacogenomic Analysis
Sponsor:
None
Organization:
None
Study Overview
Official Title:
C-PAIN Catalyzing Pharmacogenomic Analysis for Informing Pain Treatment
Status:
RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
C-PAIN
Brief Summary:
This is a randomized prospective study to evaluate the effects of preemptive pharmacogenomic PGx testing on opioid dosing decisionsselections and pain score in cancer patients
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None